Becker Capital Management Inc Organon & Co. Transaction History

Becker Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $16,941 - $24,797	-724 Reduced 7.48%	8,960 $210,000
Q2 2022 Aug 04, 2022	SELL	$31.66 - $38.9 $17,064 - $20,967	-539 Reduced 5.27%	9,684 $327,000
Q1 2022 May 12, 2022	SELL	$30.45 - $39.36 $38,580 - $49,869	-1,267 Reduced 11.03%	10,223 $357,000
Q4 2021 Feb 08, 2022	SELL	$28.67 - $37.13 $36,898 - $47,786	-1,287 Reduced 10.07%	11,490 $350,000
Q3 2021 Oct 14, 2021	SELL	$28.63 - $35.64 $730,065 - $908,820	-25,500 Reduced 66.62%	12,777 $419,000
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $1.09 Million - $1.45 Million	38,277 New	38,277 $1.16 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Becker Capital Management Inc with notifications on news.